Post-earnings recap
Reported
Wed, Aug 2, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report indicates a significant miss on EPS, which may raise concerns among investors about the company's current financial health. The stock reacted by declining 0.43%, reflecting investor uncertainty. Without specific guidance, the market may remain cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.21 | N/A | -88.42% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding the current market conditions. They emphasized the importance of their product pipeline but did not provide specific guidance.
Management did not provide specific revenue guidance for the upcoming quarters.
The company is focusing on its pipeline and upcoming product launches.